Possible reasons for this are a reluctance to use dose-banding for clinical reasons or a lack of awareness. Despite the seemingly minor change from established practice of dose preparation, dose-banding has the potential to alter patient chemotherapy exposure. The aim of this study was to ...
decreasing the dose of other medications required to treat the disease, enhancing the effect of another medication, and/or delaying the progression of the disease of patients. An
SusanElsevier LtdLancet OncologyMayor S. National Health Service England introduces dose banding. Lancet Oncol 2016;17(7):e271.Mayor, S., 2016. National Health Service England introduces dose banding. Lancet Oncol. doi:10.1016/S1470-2045(16)30199-1...
A National Survey Investigating UK Pres- cribers' Opinions on Chemotherapy Dosing and "Dose-Banding." Clin Oncol. 2009;21:320-8.Kaestner, SA, Sewell, GJ (2009) A national survey investigating UK prescribers' opinions on chemotherapy dosing and 'dose-banding'. Clin Oncol R Coll Radiol 21: ...